These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23173554)

  • 1. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
    Hompland T; Ellingsen C; Rofstad EK
    BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
    Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue of cervical carcinoma xenografts: associations with tumor hypoxia and interstitial fluid pressure and its assessment by DCE-MRI and DW-MRI.
    Hompland T; Ellingsen C; Galappathi K; Rofstad EK
    Acta Oncol; 2014 Jan; 53(1):6-15. PubMed ID: 23445339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.
    Hompland T; Ellingsen C; Øvrebø KM; Rofstad EK
    Cancer Res; 2012 Oct; 72(19):4899-908. PubMed ID: 23027087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
    Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
    J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tumor hypoxia and interstitial fluid pressure by gadomelitol-based dynamic contrast-enhanced magnetic resonance imaging.
    Gulliksrud K; Hompland T; Galappathi K; Rofstad EK
    Radiother Oncol; 2011 Oct; 101(1):217-22. PubMed ID: 21840612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
    Gulliksrud K; Brurberg KG; Rofstad EK
    Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
    Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
    Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
    Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
    Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
    Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
    Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
    Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma.
    Hompland T; Lund KV; Ellingsen C; Kristensen GB; Rofstad EK
    Radiother Oncol; 2014 Oct; 113(1):132-8. PubMed ID: 25443501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer.
    Haider MA; Sitartchouk I; Roberts TP; Fyles A; Hashmi AT; Milosevic M
    J Magn Reson Imaging; 2007 Jan; 25(1):153-9. PubMed ID: 17173303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: pharmacokinetic analysis and correlation to tumor histomorphology.
    Ellingsen C; Egeland TA; Galappathi K; Rofstad EK
    Radiother Oncol; 2010 Nov; 97(2):217-24. PubMed ID: 20656365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of single- and dual-tracer pharmacokinetic modeling of dynamic contrast-enhanced MRI data using low, medium, and high molecular weight contrast agents.
    Orth RC; Bankson J; Price R; Jackson EF
    Magn Reson Med; 2007 Oct; 58(4):705-16. PubMed ID: 17899608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.